Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.06 HKD
Change Today +0.06 / 6.00%
Volume 125.0K
8189 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin teda biomedical-h (8189) Snapshot

Open
$1.02
Previous Close
$1.00
Day High
$1.07
Day Low
$1.02
52 Week High
04/28/15 - $1.80
52 Week Low
07/8/15 - $0.37
Market Cap
1.7B
Average Volume 10 Days
327.5K
EPS TTM
$0.0096
Shares Outstanding
897.5M
EX-Date
--
P/E TM
91.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for TIANJIN TEDA BIOMEDICAL-H (8189)

Related News

No related news articles were found.

tianjin teda biomedical-h (8189) Related Businessweek News

No Related Businessweek News Found

tianjin teda biomedical-h (8189) Details

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products and health care products in the People’s Republic of China. The company markets its biological compound fertilizer products under the Fulilong brand for the promotion of balanced growth of grains, fruits, and vegetables. It also offers health care products under the Alpha brand, including diabetic health care products that helps in regulating the blood sugar level; and sugar-free products for human body. The company was founded in 2000 and is headquartered in Tianjin, the People's Republic of China.

500 Employees
Last Reported Date: 03/27/15
Founded in 2000

tianjin teda biomedical-h (8189) Top Compensated Officers

Chief Executive Officer, Compliance Officer, ...
Total Annual Compensation: CNY616.2K
Vice Chairman
Total Annual Compensation: CNY589.7K
Executive Director
Total Annual Compensation: --
Company Secretary
Total Annual Compensation: CNY150.0K
Compensation as of Fiscal Year 2014.

tianjin teda biomedical-h (8189) Key Developments

Tianjin TEDA Biomedical Engineering Company Limited Announces Nomination Committee Changes

Tianjin TEDA Biomedical Engineering Company Limited announced that Mr. Wang Shuxin has resigned as the chairman of the company and the chairman of the Nomination Committee due to his busy schedule and that he wishes to devote more time on pursuing his other business commitments with effect from 20 August 2015. Mr. Wang will continue to serve as the executive director and other positions of the company. The Board has elected Ms. Sun Li, an executive director of the company, to replace Mr. Wang as the chairman of the company and as the chairman of the Nomination Committee with effect from 20 August 2015.

Tianjin TEDA Biomedical Engineering Company Limited Approves Executive Appointments

Tianjin TEDA Biomedical Engineering Company Limited approved the appointment of Ms. Sun Li as an executive director, Mr. Chen Yingzhong as a non- executive director and Mr. Liang Weitao as an independent supervisor of the company in the extraordinary general meeting held on August 20, 2015.

Tianjin TEDA Biomedical Engineering Company Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Tianjin TEDA Biomedical Engineering Company Limited reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported turnover of RMB 273,936,694 against RMB 276,956,208 a year ago. Profit before taxation was RMB 2,325,919 against RMB 10,138,601 a year ago. Profit attributable to owners of the company was RMB 5,643,189 or 0.35 cents per basic share against RMB 9,545,517 or 0.67 cents per basic share a year ago. For the six months, the company reported turnover of RMB 143,755,207 against RMB 140,050,205 a year ago. Profit before taxation was RMB 2,403,113 against RMB 5,990,214 a year ago. Profit attributable to owners of the company was RMB 2,991,710 or 0.19 cents per basic share against RMB 5,388,355 or 0.38 cents per basic share a year ago. Net cash used in operating activities was RMB 61,189,542 against RMB 25,498,525 a year ago. Purchases of property, plant and equipment were RMB 4,791,336 against RMB 7,159,476 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8189:HK $1.06 HKD +0.06

8189 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8189.
View Industry Companies
 

Industry Analysis

8189

Industry Average

Valuation 8189 Industry Range
Price/Earnings 92.1x
Price/Sales 2.4x
Price/Book 4.5x
Price/Cash Flow 97.4x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TEDA BIOMEDICAL-H, please visit www.bioteda.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.